Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 391256, 8 pages
http://dx.doi.org/10.1155/2014/391256
Case Report

Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer

1Department of Medical Oncology, National Institute of Oncology, Rabat 10000, Morocco
2Université Mohammed V-Souissi, Rabat 8007, Morocco

Received 3 June 2014; Revised 23 September 2014; Accepted 25 September 2014; Published 21 October 2014

Academic Editor: Sercan Aksoy

Copyright © 2014 Narimane Salmi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Narimane Salmi, Ibrahim Elghissassi, Khadija Bellahammou, Asmaa Lakhdissi, Hind Mrabti, and Hassan Errihani, “Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer,” Case Reports in Oncological Medicine, vol. 2014, Article ID 391256, 8 pages, 2014. https://doi.org/10.1155/2014/391256.